{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:12:40Z","timestamp":1788487960982,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2021 SGR 00537"],"award-info":[{"award-number":["2021 SGR 00537"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["MCIN\/AEI\/https:\/\/doi.org\/10.13039\/501100011033\/FED"],"award-info":[{"award-number":["MCIN\/AEI\/https:\/\/doi.org\/10.13039\/501100011033\/FED"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PID2021-125910OB - I00"],"award-info":[{"award-number":["PID2021-125910OB - I00"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019945","name":"Direcci\u00f3 General de Recerca, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["ICREA Academia 2024"],"award-info":[{"award-number":["ICREA Academia 2024"]}],"id":[{"id":"10.13039\/501100019945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019945","name":"Direcci\u00f3 General de Recerca, Generalitat de Catalunya","doi-asserted-by":"publisher","award":["Nuclis TECARN"],"award-info":[{"award-number":["Nuclis TECARN"]}],"id":[{"id":"10.13039\/501100019945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC22\/00042"],"award-info":[{"award-number":["AC22\/00042"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["TRNSC213882FORN"],"award-info":[{"award-number":["TRNSC213882FORN"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008332","name":"Universitat Ramon Llull","doi-asserted-by":"publisher","award":["PhD fellowship IQS to Mar Losada"],"award-info":[{"award-number":["PhD fellowship IQS to Mar Losada"]}],"id":[{"id":"10.13039\/501100008332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008332","name":"Universitat Ramon Llull","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00216-026-06615-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:52:07Z","timestamp":1782201127000},"page":"5811-5834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From nucleotides to intact transcripts through oligonucleotides: Integrated chromatographic strategies for therapeutic mRNA characterization"],"prefix":"10.1007","volume":"418","author":[{"given":"Mar","family":"Losada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gotor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Borr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7014-3213","authenticated-orcid":false,"given":"Cristina","family":"Fornaguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"6615_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/pharmaceutics15020622","volume":"15","author":"H Sun","year":"2023","unstructured":"Sun H, Zhang Y, Wang G, Yang W, Xu Y. mRNA-Based therapeutics in cancer treatment. Pharmaceutics. 2023;15:622. https:\/\/doi.org\/10.3390\/pharmaceutics15020622. (MDPI).","journal-title":"Pharmaceutics"},{"key":"6615_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","volume":"20","author":"JD Beck","year":"2021","unstructured":"Beck JD, Reidenbach D, Salomon N, Sahin U, T\u00fcreci \u00d6, Vormehr M, et al. mRNA therapeutics in cancer immunotherapy. Mol Cancer. 2021;20:69. https:\/\/doi.org\/10.1186\/s12943-021-01348-0. BioMed Central Ltd.","journal-title":"Mol Cancer"},{"key":"6615_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines-a new era in vaccinology. Nat Rev Drug Discov. 2018;17:261\u201379. https:\/\/doi.org\/10.1038\/nrd.2017.243. Nature Publishing Group.","journal-title":"Nat. Rev Drug Discov"},{"key":"6615_CR4","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1039\/d1cs00617g","volume":"51","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Tang Z, Huang X, Chen W, Zhou J, Liu H, et al. Emerging mRNA technologies: delivery strategies and biomedical applications. Chem Soc Rev. 2022;51:3828\u201345. https:\/\/doi.org\/10.1039\/d1cs00617g. Royal Society of Chemistry.","journal-title":"Chem Soc Rev"},{"key":"6615_CR5","doi-asserted-by":"publisher","unstructured":"Zhong L, Li Y, Xiong L, Wang W, Wu M, Yuan T, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther; 2021. https:\/\/doi.org\/10.1038\/s41392-021-00572-w. Springer Nature.","DOI":"10.1038\/s41392-021-00572-w"},{"key":"6615_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12967-024-06033-6","volume":"23","author":"Q Fu","year":"2025","unstructured":"Fu Q, Zhao X, Hu J, Jiao Y, Yan Y, Pan X, et al. mRNA vaccines in the context of cancer treatment: from concept to application. J Transl Med. 2025;23:12. https:\/\/doi.org\/10.1186\/s12967-024-06033-6. BioMed Central Ltd.","journal-title":"J Transl Med"},{"key":"6615_CR7","doi-asserted-by":"publisher","first-page":"102721","DOI":"10.1016\/j.omtn.2025.102721","volume":"36","author":"MA Ige","year":"2025","unstructured":"Ige MA, Ren X, Yang Y, Zhang H, Shen C, Jiang Y, et al. mRNA therapeutics: Transforming medicine through innovation in design, delivery, and disease treatment. Mol Ther Nucleic Acids. 2025;36:102721. https:\/\/doi.org\/10.1016\/j.omtn.2025.102721. Cell Press.","journal-title":"Mol Ther Nucleic Acids"},{"key":"6615_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3 K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23:165\u201375. https:\/\/doi.org\/10.1016\/j.immuni.2005.06.008.","journal-title":"Immunity."},{"key":"6615_CR9","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood American Society of Hematology. 2006;108:4009\u201317. https:\/\/doi.org\/10.1182\/blood-2006-04-015024.","journal-title":"Blood. American Society of Hematology"},{"key":"6615_CR10","doi-asserted-by":"publisher","unstructured":"Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Mol Ther; 2019; 710\u201328. https:\/\/doi.org\/10.1016\/j.ymthe.2019.02.012. Cell Press.","DOI":"10.1016\/j.ymthe.2019.02.012"},{"key":"6615_CR11","doi-asserted-by":"publisher","unstructured":"Sahin U, Karik\u00f3 K, T\u00fcreci \u00d6. mRNA-based therapeutics-developing a new class of drugs. Nat Rev Drug Discov; 2014; 759\u201380. https:\/\/doi.org\/10.1038\/nrd4278. Nature Publishing Group.","DOI":"10.1038\/nrd4278"},{"key":"6615_CR12","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3 K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther. 2008;16:1833\u201340. https:\/\/doi.org\/10.1038\/mt.2008.200. Nature Publishing Group.","journal-title":"Mol Ther"},{"key":"6615_CR13","doi-asserted-by":"publisher","unstructured":"Quan Y, Yang H, Li W, Li L. mRNA vaccines: immunogenicity and quality characteristics. J Nanobiotechnol. 2026. https:\/\/doi.org\/10.1186\/s12951-025-03800-5. BioMed Central Ltd.","DOI":"10.1186\/s12951-025-03800-5"},{"key":"6615_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41587-024-02306-z","volume":"43","author":"JE McGee","year":"2025","unstructured":"McGee JE, Kirsch JR, Kenney D, Cerbo F, Chavez EC, Shih TY, et al. Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency. Nat Biotechnol. 2025;43:720\u20136. https:\/\/doi.org\/10.1038\/s41587-024-02306-z. Nature Research.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"6615_CR15","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1073\/pnas.72.2.742","volume":"72","author":"Y Furuichi","year":"1975","unstructured":"Furuichi Y, Muthukrishnan S, Shatkin AJ. 5\u2019-Terminal m7G(5\u2019)ppp(5\u2019)Gmp In Vivo: identification in Reovirus Genome RNA (7-methylguanosine\/double-stranded RNA\/methylation). PNAS. 1975;72(2):742\u20135.","journal-title":"PNAS"},{"key":"6615_CR16","doi-asserted-by":"publisher","unstructured":"Castillo-Hair S, Fedak S, Wang B, Linder J, Havens K, Certo M, et al. Optimizing 5\u2019UTRs for mRNA-delivered gene editing using deep learning. Nat Commun. 2024;15. https:\/\/doi.org\/10.1038\/s41467-024-49508-2. Nature Research.","DOI":"10.1038\/s41467-024-49508-2"},{"key":"6615_CR17","doi-asserted-by":"publisher","unstructured":"Oh A, Lee S, Park HJ, Yoon S, Ha D, Lee J, et al. Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability. NPJ Vaccines; 2025;10. https:\/\/doi.org\/10.1038\/s41541-025-01287-7. Nature Research.","DOI":"10.1038\/s41541-025-01287-7"},{"key":"6615_CR18","doi-asserted-by":"publisher","unstructured":"Karik\u00f3 K. In vitro-Transcribed mRNA Therapeutics: out of the shadows and into the spotlight. Mol Ther. 2019; 691\u20132. https:\/\/doi.org\/10.1016\/j.ymthe.2019.03.009. Cell Press.","DOI":"10.1016\/j.ymthe.2019.03.009"},{"key":"6615_CR19","doi-asserted-by":"publisher","unstructured":"Kang DD, Li H, Dong Y. Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics. Adv Drug Deliv Rev. 2023. https:\/\/doi.org\/10.1016\/j.addr.2023.114961. Elsevier B.V.","DOI":"10.1016\/j.addr.2023.114961"},{"key":"6615_CR20","doi-asserted-by":"publisher","unstructured":"Sekirnik R, Kuhn AN, Azevedo AM, Kis Z. Editorial: In vitro transcription (IVT) reaction \u2013 the gateway to new therapeutic modalities. Front Mol Biosc. 2025;12. https:\/\/doi.org\/10.3389\/fmolb.2025.1730880. Frontiers Media SA.","DOI":"10.3389\/fmolb.2025.1730880"},{"key":"6615_CR21","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1021\/acs.accounts.3c00442","volume":"56","author":"M Warminski","year":"2023","unstructured":"Warminski M, Mamot A, Depaix A, Kowalska J, Jemielity J. Chemical modifications of mRNA ends for therapeutic applications. Acc Chem Res. 2023;56:2814\u201326. https:\/\/doi.org\/10.1021\/acs.accounts.3c00442. American Chemical Society.","journal-title":"Acc Chem Res"},{"key":"6615_CR22","volume-title":"ICH Topic Q6B: specifications: test procedures and acceptance criteria for biotechnological\/biological products","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)","year":"1999","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Topic Q6B: specifications: test procedures and acceptance criteria for biotechnological\/biological products. EMA Guidelines webpage; 1999."},{"key":"6615_CR23","volume-title":"Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases: regulatory considerations","author":"World Health Organization Expert Committee on Biological Standardization","year":"2021","unstructured":"World Health Organization Expert Committee on Biological Standardization. Evaluation of the quality, safety and efficacy of messenger RNA vaccines for the prevention of infectious diseases: regulatory considerations. WHO application notes; 2021."},{"key":"6615_CR24","unstructured":"United States Pharmacopeia (USP). Analytical procedures for quality of mRNA vaccines and therapeutics. Draft Guidelines: 1st eedition. 2022."},{"key":"6615_CR25","unstructured":"United States Pharmacopeia (USP). Analytical procedures for quality of mRNA vaccines and therapeutics. Draft Guidelines: 2nd edition. 2023."},{"key":"6615_CR26","unstructured":"United States Pharmacopeia (USP). Analytical procedures for quality of mRNA vaccines and therapeutics. Draft Guidelines: 3rd edition. 2024."},{"key":"6615_CR27","volume-title":"Concept paper on the development of a guideline on the quality aspects of mRNA vaccines","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2023","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Concept paper on the development of a guideline on the quality aspects of mRNA vaccines. 2023."},{"key":"6615_CR28","volume-title":"Guideline on the quality aspects of mRNA vaccines","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2025","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on the quality aspects of mRNA vaccines. 2025"},{"key":"6615_CR29","doi-asserted-by":"publisher","unstructured":"Saxena T, Sharvani A, Stavika A, Rohini M. Regulatory considerations for messenger RNA vaccines: A comprehensive review on World Health Organization guidelines on development, production, and clinical evaluation. Perspect Clin Res. 2025. https:\/\/doi.org\/10.4103\/picr.picr_199_25","DOI":"10.4103\/picr.picr_199_25"},{"key":"6615_CR30","unstructured":"European Pharmacopoeia Commission adopts first three general texts on mRNA vaccines. 2025."},{"key":"6615_CR31","volume-title":"Principles of nucleic acid structure","author":"N Stephen","year":"2008","unstructured":"Stephen N. Principles of nucleic acid structure. Elsevier\u00a0; Academic Press; 2008."},{"key":"6615_CR32","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.15252\/embj.201694818","volume":"35","author":"P L\u00f6ssl","year":"2016","unstructured":"L\u00f6ssl P, van de Waterbeemd M, Heck AJ. The diverse and expanding role of mass spectrometry in structural and molecular biology. EMBO J. 2016;35:2634\u201357. https:\/\/doi.org\/10.15252\/embj.201694818. Springer Science and Business Media LLC.","journal-title":"EMBO J"},{"key":"6615_CR33","doi-asserted-by":"publisher","unstructured":"Santos IC, Brodbelt JS. Recent developments in the characterization of nucleic acids by liquid chromatography, capillary electrophoresis, ion mobility, and mass spectrometry (2010\u20132020). J Sep Sci. 2021; 340\u201372. https:\/\/doi.org\/10.1002\/jssc.202000833. Wiley-VCH Verlag.","DOI":"10.1002\/jssc.202000833"},{"key":"6615_CR34","doi-asserted-by":"publisher","unstructured":"Gritti F. Absorption and escape kinetics of spherical biomolecules from fully porous particles utilized in size exclusion chromatography. J Chromatogr A. 2023;1701. https:\/\/doi.org\/10.1016\/j.chroma.2023.464050. Elsevier B.V.","DOI":"10.1016\/j.chroma.2023.464050"},{"key":"6615_CR35","doi-asserted-by":"publisher","unstructured":"Fekete S, Doneanu C, Addepalli B, Gaye M, Nguyen J, Alden B, et al. Challenges and emerging trends in liquid chromatography-based analyses of mRNA pharmaceuticals. J Pharm Biomed Anal. 2023. https:\/\/doi.org\/10.1016\/j.jpba.2022.115174. Elsevier B.V.","DOI":"10.1016\/j.jpba.2022.115174"},{"key":"6615_CR36","doi-asserted-by":"publisher","unstructured":"Hengesbach M, Chan CK, Bhandari T, Bruzel A, DeMott MS, Podoprygorina G, et al. Toward standardized epitranscriptome analytics: an inter-laboratory comparison of mass spectrometric detection and quantification of modified ribonucleosides in human RNA. Nucleic Acids Res. 2025;53. https:\/\/doi.org\/10.1093\/nar\/gkaf895. Oxford University Press.","DOI":"10.1093\/nar\/gkaf895"},{"key":"6615_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrg.2016.169","volume":"18","author":"M Helm","year":"2017","unstructured":"Helm M, Motorin Y. Detecting RNA modifications in the epitranscriptome: predict and validate. Nat Rev Genet. 2017;18:275\u201391. https:\/\/doi.org\/10.1038\/nrg.2016.169.","journal-title":"Nat Rev Genet"},{"key":"6615_CR38","doi-asserted-by":"publisher","unstructured":"Crain PF. Preparation and enzymatic hydrolysis of DNA and RNA for mass spectrometry. Methods Enzymol. 1990;782\u201390. https:\/\/doi.org\/10.1016\/0076-6879(90)93450-Y.","DOI":"10.1016\/0076-6879"},{"key":"6615_CR39","doi-asserted-by":"publisher","unstructured":"Sakaguchi Y, Miyauchi K, Kang B-i, Suzuki T. Nucleoside analysis by Hydrophilic Interaction Liquid Chromatography coupled with mass spectrometry. Methods Enzymol. 2015:19\u201328. https:\/\/doi.org\/10.1016\/bs.mie.2015.03.015.","DOI":"10.1016\/bs.mie.2015.03.015"},{"key":"6615_CR40","doi-asserted-by":"publisher","unstructured":"Straube H, Witte C-P, Herde M. Analysis of nucleosides and nucleotides in plants: an update on sample preparation and LC-MS Techniques. 2021. https:\/\/doi.org\/10.3390\/cells.","DOI":"10.3390\/cells"},{"key":"6615_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/308062","volume":"2012","author":"D Garc\u00eda-G\u00f3mez","year":"2012","unstructured":"Garc\u00eda-G\u00f3mez D, Rodr\u00edguez-Gonzalo E, Carabias-Mart\u00ednez R. Evaluation of the electrostatic contribution to the retention of modified nucleosides and nucleobases by Zwitterionic hydrophilic interaction chromatography. ISRN Anal Chem. 2012;2012:1\u20135. https:\/\/doi.org\/10.5402\/2012\/308062. Hindawi Limited.","journal-title":"ISRN Anal Chem"},{"key":"6615_CR42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s13361-019-02140-7","volume":"30","author":"L He","year":"2019","unstructured":"He L, Wei X, Ma X, Yin X, Song M, Donninger H, et al. Simultaneous quantification of nucleosides and nucleotides from biological samples. J Am Soc Mass Spectrom. 2019;30:987\u20131000. https:\/\/doi.org\/10.1007\/s13361-019-02140-7.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6615_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/mas.21388","volume":"33","author":"E Dudley","year":"2014","unstructured":"Dudley E, Bond L. Mass spectrometry analysis of nucleosides and nucleotides. Mass Spectrom Rev. 2014;33:302\u201331. https:\/\/doi.org\/10.1002\/mas.21388.","journal-title":"Mass Spectrom Rev."},{"key":"6615_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbagrm.2018.10.012","volume":"1862","author":"M Jora","year":"2019","unstructured":"Jora M, Lobue PA, Ross RL, Williams B, Addepalli B. Detection of ribonucleoside modifications by liquid chromatography coupled with mass spectrometry. Biochim Biophys Acta Gene Regul Mech. 2019;1862:280\u201390. Elsevier B.V.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"6615_CR45","doi-asserted-by":"publisher","unstructured":"Gautam N, Alamoudi JA, Kumar S, Alnouti Y. Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples. J Pharm Biomed Anal. 2020. https:\/\/doi.org\/10.1016\/j.jpba.2019.112902. Elsevier B.V.","DOI":"10.1016\/j.jpba.2019.112902"},{"key":"6615_CR46","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1016\/j.jchromb.2009.09.030","volume":"877","author":"S Cohen","year":"2009","unstructured":"Cohen S, Megherbi M, Jordheim LP, Lefebvre I, Perigaud C, Dumontet C, et al. Simultaneous analysis of eight nucleoside triphosphates in cell lines by liquid chromatography coupled with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:3831\u201340. https:\/\/doi.org\/10.1016\/j.jchromb.2009.09.030.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"6615_CR47","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1039\/d5an00033e","volume":"150","author":"EN Welbourne","year":"2025","unstructured":"Welbourne EN, Copley RJ, Owen GR, Evans CA, Isoko K, Cook K, et al. Mass spectrometry-based mRNA sequence mapping via complementary RNase digests and bespoke visualisation tools. Anal R Soc Chem. 2025;150:1012\u201321. https:\/\/doi.org\/10.1039\/d5an00033e.","journal-title":"Anal R Soc Chem"},{"key":"6615_CR48","doi-asserted-by":"publisher","first-page":"8500","DOI":"10.1021\/acs.analchem.9b01664","volume":"91","author":"T Jiang","year":"2019","unstructured":"Jiang T, Yu N, Kim J, Murgo JR, Kissai M, Ravichandran K, et al. Oligonucleotide sequence mapping of large therapeutic mRNAs via Parallel ribonuclease digestions and LC-MS\/MS. Anal Chem. 2019;91:8500\u20136. https:\/\/doi.org\/10.1021\/acs.analchem.9b01664. American Chemical Society.","journal-title":"Anal Chem"},{"key":"6615_CR49","doi-asserted-by":"publisher","first-page":"14792","DOI":"10.1021\/acs.analchem.1c03533","volume":"93","author":"A Goyon","year":"2021","unstructured":"Goyon A, Scott B, Kurita K, Crittenden CM, Shaw D, Lin A, et al. Full sequencing of CRISPR\/Cas9 single guide RNA (sgRNA) via Parallel Ribonuclease digestions and hydrophilic interaction liquid chromatography-high-resolution mass spectrometry analysis. Anal Chem. 2021;93:14792\u2013801. https:\/\/doi.org\/10.1021\/acs.analchem.1c03533. American Chemical Society.","journal-title":"Anal Chem"},{"key":"6615_CR50","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.1021\/acs.analchem.2c00765","volume":"94","author":"CJ Vanhinsbergh","year":"2022","unstructured":"Vanhinsbergh CJ, Criscuolo A, Sutton JN, Murphy K, Williamson AJK, Cook K, et al. Characterization and sequence mapping of large RNA and mRNA therapeutics using mass spectrometry. Anal Chem. 2022;94:7339\u201349. https:\/\/doi.org\/10.1021\/acs.analchem.2c00765. American Chemical Society.","journal-title":"Anal Chem"},{"key":"6615_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/oxfordjournals.jbchem.a129239","volume":"67","author":"T Uchida","year":"1970","unstructured":"Uchida T, Arima T, Egami F. Specificity of RNase U2. J Biochem. 1970;67:91\u2013102. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a129239.","journal-title":"J Biochem"},{"key":"6615_CR52","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1007\/s00216-017-0500-x","volume":"409","author":"B Addepalli","year":"2017","unstructured":"Addepalli B, Venus S, Thakur P, Limbach PA. Novel ribonuclease activity of cusativin from Cucumis sativus for mapping nucleoside modifications in RNA. Anal Bioanal Chem. 2017;409:5645\u201354. https:\/\/doi.org\/10.1007\/s00216-017-0500-x.","journal-title":"Anal Bioanal Chem"},{"key":"6615_CR53","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1261\/rna.052472.115","volume":"21","author":"B Addepalli","year":"2015","unstructured":"Addepalli B, Lesner NP, Limbach PA. Detection of RNA nucleoside modifications with the uridinespecific ribonuclease MC1 from Momordica charantia. RNA. 2015;21:1746\u201356. https:\/\/doi.org\/10.1261\/rna.052472.115. Cold Spring Harbor Laboratory Press.","journal-title":"RNA"},{"key":"6615_CR54","doi-asserted-by":"publisher","unstructured":"Thakur P, Atway J, Limbach PA, Addepalli B. RNA Cleavage properties of nucleobase-specific RNase MC1 and cusativin are determined by the Dinucleotide-binding interactions in the enzyme-active site. Int J Mol Sci; 2022;23. https:\/\/doi.org\/10.3390\/ijms23137021. MDPI","DOI":"10.3390\/ijms23137021"},{"key":"6615_CR55","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.1093\/nar\/gkac632","volume":"50","author":"EJ Wolf","year":"2022","unstructured":"Wolf EJ, Gr\u00fcnberg S, Dai N, Chen TH, Roy B, Yigit E, et al. Human RNase 4 improves mRNA sequence characterization by LC-MS\/MS. Nucleic Acids Res. 2022;50:E106\u2013E106. https:\/\/doi.org\/10.1093\/nar\/gkac632. Oxford University Press.","journal-title":"Nucleic Acids Res"},{"key":"6615_CR56","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1093\/nar\/gkl629","volume":"34","author":"T Ogawa","year":"2006","unstructured":"Ogawa T, Inoue S, Yajima S, Hidaka M, Masaki H. Sequence-specific recognition of colicin E5, a tRNA-targeting ribonuclease. Nucleic Acids Res. 2006;34:6065\u201373. https:\/\/doi.org\/10.1093\/nar\/gkl629.","journal-title":"Nucleic Acids Res"},{"key":"6615_CR57","doi-asserted-by":"publisher","unstructured":"Miyamoto T, Kato Y, Sekiguchi Y, Tsuneda S, Noda N. Characterization of mazF-mediated sequence-specific RNA cleavage in pseudomonas putida using massive parallel sequencing. PLoS One; 2016;11. https:\/\/doi.org\/10.1371\/journal.pone.0149494. Public Library of Science.","DOI":"10.1371\/journal.pone.0149494"},{"key":"6615_CR58","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/MAS.10011","volume":"20","author":"CG Huber","year":"2001","unstructured":"Huber CG, Oberacher H. Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry. Mass Spectrom Rev. 2001;20:310\u201343. https:\/\/doi.org\/10.1002\/MAS.10011.","journal-title":"Mass Spectrom Rev"},{"key":"6615_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0021-9673(02)00306-0","volume":"958","author":"M Gilar","year":"2002","unstructured":"Gilar M, Fountain KJ, Budman Y, Neue UD, Yardley KR, Rainville PD, et al. Ion-pair reversed-phase high-performance liquid chromatography analysis of oligonucleotides: J Chromatogr A. 2002;958:167\u201382. https:\/\/doi.org\/10.1016\/S0021-9673(02)00306-0.","journal-title":"J Chromatogr A"},{"key":"6615_CR60","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1021\/AC960916H","volume":"69","author":"A Apffel","year":"1997","unstructured":"Apffel A, Chakel JA, Fischer S, Lichtenwalter K, Hancock WS. Analysis of oligonucleotides by HPLC-electrospray ionization mass spectrometry. Anal Chem. 1997;69:1320\u20135. https:\/\/doi.org\/10.1021\/AC960916H.","journal-title":"Anal Chem"},{"key":"6615_CR61","doi-asserted-by":"publisher","first-page":"100079","DOI":"10.1016\/J.JCOA.2023.100079","volume":"3","author":"T Fornstedt","year":"2023","unstructured":"Fornstedt T, Enmark M. Separation of therapeutic oligonucleotides using ion-pair reversed-phase chromatography based on fundamental separation science. J Chromatogr Open. 2023;3:100079. https:\/\/doi.org\/10.1016\/J.JCOA.2023.100079. Elsevier.","journal-title":"J Chromatogr Open"},{"key":"6615_CR62","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1007\/s00216-019-01819-w","volume":"411","author":"G Weng","year":"2019","unstructured":"Weng G, Sun B, Liu Z, Wang F, Pan Y. Analysis of oligonucleotides by ion-pair reversed-phase liquid chromatography coupled with positive mode electrospray ionization mass spectrometry. Anal Bioanal Chem. 2019;411:4167\u201373. https:\/\/doi.org\/10.1007\/s00216-019-01819-w.","journal-title":"Anal Bioanal Chem"},{"key":"6615_CR63","doi-asserted-by":"publisher","first-page":"462860","DOI":"10.1016\/j.chroma.2022.462860","volume":"1666","author":"M Donegan","year":"2022","unstructured":"Donegan M, Nguyen JM, Gilar M. Effect of ion-pairing reagent hydrophobicity on liquid chromatography and mass spectrometry analysis of oligonucleotides. J Chromatogr A. 2022;1666:462860. https:\/\/doi.org\/10.1016\/j.chroma.2022.462860. Elsevier B.V.","journal-title":"J Chromatogr A"},{"key":"6615_CR64","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s13361-017-1671-6","volume":"28","author":"B Basiri","year":"2017","unstructured":"Basiri B, Murph MM, Bartlett MG. Assessing the interplay between the physicochemical parameters of ion-pairing reagents and the analyte sequence on the electrospray desorption process for oligonucleotides. J Am Soc Mass Spectrom. 2017;28:1647\u201356. https:\/\/doi.org\/10.1007\/s13361-017-1671-6. Springer New York LLC.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6615_CR65","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1021\/jasms.3c00264","volume":"34","author":"GJ Guimaraes","year":"2023","unstructured":"Guimaraes GJ, Saad JG, Annavarapu V, Bartlett MG. Mobile Phase Aging and Its Impact on Electrospray Ionization of Oligonucleotides. J Am Soc Mass Spectrom. 2023;34:2691\u20139. https:\/\/doi.org\/10.1021\/jasms.3c00264. American Chemical Society.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6615_CR66","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s13361-016-1500-3","volume":"28","author":"B Basiri","year":"2017","unstructured":"Basiri B, van Hattum H, van Dongen WD, Murph MM, Bartlett MG. The Role of Fluorinated Alcohols as Mobile Phase Modifiers for LC-MS Analysis of Oligonucleotides. J Am Soc Mass Spectrom. 2017;28:190\u20139. https:\/\/doi.org\/10.1007\/s13361-016-1500-3. Springer New York LLC.","journal-title":"J Am Soc Mass Spectrom"},{"key":"6615_CR67","doi-asserted-by":"publisher","unstructured":"Guimaraes GJ, Bartlett MG. The critical role of mobile phase pH in the performance of oligonucleotide ion-pair liquid chromatography-mass spectrometry methods. Future Sci OA. 2021. https:\/\/doi.org\/10.2144\/fsoa-2021-0084. Future Medicine Ltd.","DOI":"10.2144\/fsoa-2021-0084"},{"key":"6615_CR68","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1039\/D4AN01155D","volume":"150","author":"S Abernathy","year":"2025","unstructured":"Abernathy S, Rayhan A, Limbach PA. Stationary phase effects in hydrophilic interaction liquid chromatographic separation of oligonucleotides. Analyst. 2025;150:185\u201396. https:\/\/doi.org\/10.1039\/D4AN01155D.","journal-title":"Analyst."},{"key":"6615_CR69","doi-asserted-by":"publisher","first-page":"117758","DOI":"10.1016\/J.TRAC.2024.117758","volume":"176","author":"H Lardeux","year":"2024","unstructured":"Lardeux H, D\u2019Atri V, Guillarme D. Recent advances and current challenges in hydrophilic interaction chromatography for the analysis of therapeutic oligonucleotides. TrAC Trends Anal Chem. 2024;176:117758. https:\/\/doi.org\/10.1016\/J.TRAC.2024.117758. Elsevier.","journal-title":"TrAC Trends Anal Chem"},{"key":"6615_CR70","doi-asserted-by":"publisher","unstructured":"Fekete S, Araya M, Addepalli B, Lauber M. Hydrophilic interaction liquid chromatography for oligonucleotide therapeutics: Method consideration. LCGC international. 2025;20\u20136. https:\/\/doi.org\/10.56530\/lcgc.int.et8776w7","DOI":"10.56530\/lcgc.int.et8776w7"},{"key":"6615_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.chroma.2019.02.016","volume":"1595","author":"PA Lobue","year":"2019","unstructured":"Lobue PA, Jora M, Addepalli B, Limbach PA. Oligonucleotide analysis by hydrophilic interaction liquid chromatography-mass spectrometry in the absence of ion-pair reagents. J Chromatogr A. 2019;1595:39\u201348. https:\/\/doi.org\/10.1016\/j.chroma.2019.02.016.","journal-title":"J Chromatogr A."},{"key":"6615_CR72","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1039\/d4an00484a","volume":"149","author":"M Rahman","year":"2024","unstructured":"Rahman M, Marzullo BP, Lam PY, Barrow MP, Holman SW, Ray AD, et al. Unveiling the intricacy of gapmer oligonucleotides through advanced tandem mass spectrometry approaches and scan accumulation for 2DMS. Analyst. 2024;149:4687\u2013701. https:\/\/doi.org\/10.1039\/d4an00484a. Royal Society of Chemistry.","journal-title":"Analyst"},{"key":"6615_CR73","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3390\/molecules28031169","volume":"28","author":"C Gawlig","year":"2023","unstructured":"Gawlig C, R\u00fchl M. Investigation of the influence of charge state and collision energy on oligonucleotide fragmentation by Tandem mass spectrometry. Molecules. 2023;28:1169. https:\/\/doi.org\/10.3390\/molecules28031169. MDPI.","journal-title":"Molecules"},{"key":"6615_CR74","doi-asserted-by":"publisher","first-page":"15386","DOI":"10.1021\/acs.analchem.2c03187","volume":"94","author":"D Ghosh","year":"2022","unstructured":"Ghosh D, Rosu F, Gabelica V. Negative electrospray supercharging mechanisms of nucleic acid structures. Anal Chem. 2022;94:15386\u201394. https:\/\/doi.org\/10.1021\/acs.analchem.2c03187.","journal-title":"Anal Chem."},{"key":"6615_CR75","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s13361-019-02152-3","volume":"30","author":"N Khristenko","year":"2019","unstructured":"Khristenko N, Amato J, Livet S, Pagano B, Randazzo A, Gabelica V. Native ion mobility mass spectrometry: when gas-phase ion structures depend on the electrospray charging process. J Am Soc Mass Spectrom. 2019;30:1069\u201381. https:\/\/doi.org\/10.1007\/s13361-019-02152-3.","journal-title":"J Am Soc Mass Spectrom."},{"key":"6615_CR76","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s00216-025-05861-9","volume":"417","author":"Y Wu","year":"2025","unstructured":"Wu Y, Wang Y. A comparative study of data-independent acquisition and data-dependent acquisition in liquid chromatography-mass spectrometry-based untargeted metabolomics analysis of Panax genus sample. Anal Bioanal Chem. 2025;417:3215\u201328. https:\/\/doi.org\/10.1007\/s00216-025-05861-9.","journal-title":"Anal Bioanal Chem."},{"key":"6615_CR77","doi-asserted-by":"publisher","unstructured":"Krasny L, Huang PH. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Mol Omics; 2021; 29\u201342. https:\/\/doi.org\/10.1039\/d0mo00072h. Royal Society of Chemistry.","DOI":"10.1039\/d0mo00072h"},{"key":"6615_CR78","doi-asserted-by":"publisher","unstructured":"Wein S. Analysis of RNA sequences and modifications using NASE. 2023; 225\u201339. https:\/\/doi.org\/10.1007\/978-1-0716-2962-8_15","DOI":"10.1007\/978-1-0716-2962-8_15"},{"key":"6615_CR79","doi-asserted-by":"publisher","unstructured":"Wein S, Andrews B, Sachsenberg T, Santos-Rosa H, Kohlbacher O, Kouzarides T, et al. A computational platform for high-throughput analysis of RNA sequences and modifications by mass spectrometry. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-14665-7. Nature Research.","DOI":"10.1038\/s41467-020-14665-7"},{"key":"6615_CR80","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/1044-0305(92)85019-G","volume":"3","author":"SA Mcluckey","year":"1992","unstructured":"Mcluckey SA, Van Berkel GJ, Glish GL. Tandem Mass Spectrometry of Small, Multiply Charged Oligonucleotides. J Am Soc Mass Spectrom. 1992;3:60\u201370. https:\/\/doi.org\/10.1016\/1044-0305(92)85019-G.","journal-title":"J Am Soc Mass Spectrom."},{"key":"6615_CR81","doi-asserted-by":"publisher","unstructured":"Maurer J, Vanluchene H, Tsalmpouris A, Morreel K, Camperi J, Sandra K, et al. Exploring the potential of oligonucleotide mapping with liquid chromatography \u2013 mass spectrometry to study the primary structure of mRNA. TrAC - Trends Anal Chem; 2025. https:\/\/doi.org\/10.1016\/j.trac.2025.118309. Elsevier B.V.","DOI":"10.1016\/j.trac.2025.118309"},{"key":"6615_CR82","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1039\/D5AN00033E","volume":"150","author":"EN Welbourne","year":"2025","unstructured":"Welbourne EN, Copley RJ, Owen GR, Evans CA, Isoko K, Cook K, et al. Mass spectrometry-based mRNA sequence mapping via complementary RNase digests and bespoke visualisation tools. Analyst. 2025;150:1012\u201321. https:\/\/doi.org\/10.1039\/D5AN00033E. Royal Society of Chemistry.","journal-title":"Analyst"},{"key":"6615_CR83","doi-asserted-by":"publisher","unstructured":"Jiang T, Yu N, Kim J, Murgo J-R, Kissai M, Ravichandran K, et al. Oligonucleotide sequence mapping of large therapeutic mRNAs via parallel ribonuclease digestions and LC-MS\/MS. 2019. https:\/\/doi.org\/10.1021\/acs.analchem.9b01664","DOI":"10.1021\/acs.analchem.9b01664"},{"key":"6615_CR84","doi-asserted-by":"publisher","unstructured":"M L. mRNA Purifications Process: Affinity Chromato-Graphy, Magnetic Beads and Graphene Coated Large Scale Production and Toxicological Aspects. Curr Investig Clin Med Res; 2022;2. https:\/\/doi.org\/10.53902\/cicmr.2022.02.000517. Stephy Publishers.","DOI":"10.53902\/cicmr.2022.02.000517"},{"key":"6615_CR85","doi-asserted-by":"publisher","unstructured":"Oberacker P, Stepper P, Bond DM, H\u00f6hn S, Focken J, Meyer V, et al. Bio-On-Magnetic-Beads (BOMB): Open platform for high-throughput nucleic acid extraction and manipulation. PLoS Biol; 2019;17. https:\/\/doi.org\/10.1371\/journal.pbio.3000107. Public Library of Science.","DOI":"10.1371\/journal.pbio.3000107"},{"key":"6615_CR86","doi-asserted-by":"publisher","unstructured":"Adams NM, Bordelon H, Wang K-KA, Albert LE, Wright DW, Haselton FR. Comparison of three magnetic bead surface functionalities for RNA extraction and detection. ACS Appl Mater Interfaces. 2015;7:6062\u20139. https:\/\/doi.org\/10.1021\/am506374t","DOI":"10.1021\/am506374t"},{"key":"6615_CR87","doi-asserted-by":"publisher","first-page":"pdb.prot101733","DOI":"10.1101\/pdb.prot101733","volume":"2019","author":"MR Green","year":"2019","unstructured":"Green MR, Sambrook J. Isolation of Poly(A) Messenger RNA Using Magnetic Oligo(dT) Beads. Cold Spring Harb Protoc. 2019;2019:pdb.prot101733. https:\/\/doi.org\/10.1101\/pdb.prot101733.","journal-title":"Cold Spring Harb Protoc."},{"key":"6615_CR88","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1007\/s00216-016-9605-x","volume":"408","author":"M Beverly","year":"2016","unstructured":"Beverly M, Dell A, Parmar P, Houghton L. Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS. Anal Bioanal Chem. 2016;408:5021\u201330. https:\/\/doi.org\/10.1007\/s00216-016-9605-x.","journal-title":"Anal Bioanal Chem"},{"key":"6615_CR89","doi-asserted-by":"publisher","first-page":"465574","DOI":"10.1016\/j.chroma.2024.465574","volume":"1740","author":"J Maurer","year":"2025","unstructured":"Maurer J, Malburet C, Fran\u00e7ois-Heude M, Guillarme D. Evaluation of ion pairing reversed-phase liquid chromatography for the separation of large RNA molecules. J Chromatogr A. 2025;1740:465574. https:\/\/doi.org\/10.1016\/j.chroma.2024.465574.","journal-title":"J Chromatogr A."},{"key":"6615_CR90","doi-asserted-by":"publisher","first-page":"6254","DOI":"10.3390\/ijms25116254","volume":"25","author":"V D\u2019Atri","year":"2024","unstructured":"D\u2019Atri V, Lardeux H, Goyon A, Imio\u0142ek M, Fekete S, Lauber M, et al. Optimizing messenger RNA analysis using ultra-wide pore size exclusion chromatography columns. Int J Mol Sci. 2024;25:6254. https:\/\/doi.org\/10.3390\/ijms25116254.","journal-title":"Int J Mol Sci."},{"key":"6615_CR91","doi-asserted-by":"publisher","first-page":"14308","DOI":"10.1021\/acs.analchem.3c02552","volume":"95","author":"M Gilar","year":"2023","unstructured":"Gilar M, Doneanu C, Gaye MM. Liquid chromatography methods for analysis of mRNA Poly(A) tail length and heterogeneity. Anal Chem. 2023;95:14308\u201316. https:\/\/doi.org\/10.1021\/acs.analchem.3c02552. American Chemical Society.","journal-title":"Anal Chem"},{"key":"6615_CR92","doi-asserted-by":"publisher","unstructured":"Fekete S, Yang H, Wyndham K, Lauber M. Salt gradient and ion-pair mediated anion exchange of intact messenger ribonucleic acids. Journal of Chromatography Open 2022;2. https:\/\/doi.org\/10.1016\/j.jcoa.2022.100031. Elsevier B.V.","DOI":"10.1016\/j.jcoa.2022.100031"},{"key":"6615_CR93","doi-asserted-by":"publisher","first-page":"462247","DOI":"10.1016\/J.CHROMA.2021.462247","volume":"1650","author":"M Gilar","year":"2021","unstructured":"Gilar M, DeLano M, Gritti F. Mitigation of analyte loss on metal surfaces in liquid chromatography. J Chromatogr A. 2021;1650:462247. https:\/\/doi.org\/10.1016\/J.CHROMA.2021.462247. Elsevier.","journal-title":"J Chromatogr A"},{"key":"6615_CR94","doi-asserted-by":"publisher","unstructured":"Guimaraes GJ, Sutton JM, Gilar M, Donegan M, Bartlett MG. Impact of nonspecific adsorption to metal surfaces in Ion Pair-RP LC-MS Impurity analysis of oligonucleotides. J Pharm Biomed Anal. 2022;208. https:\/\/doi.org\/10.1016\/J.JPBA.2021.114439","DOI":"10.1016\/J.JPBA.2021.114439"},{"key":"6615_CR95","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1021\/ACS.ANALCHEM.0C05203","volume":"03","author":"M Delano","year":"2021","unstructured":"Delano M, Walter TH, Lauber MA, Gilar M, Jung MC, Nguyen JM, et al. Using hybrid organic-inorganic surface technology to mitigate analyte interactions with metal surfaces in UHPLC. Anal Chem. 2021;03:5773\u201381. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.0C05203. American Chemical Society.","journal-title":"Anal Chem."},{"key":"6615_CR96","doi-asserted-by":"publisher","unstructured":"Yamamoto T, Yoshida T, Uchida Y, Ohoka N, Yamashita T, Uchida E, et al. Analytical factors for optimization of chain-length distribution analysis of mRNA using capillary gel electrophoresis. J Chromatogr A. 2025;1754. https:\/\/doi.org\/10.1016\/j.chroma.2025.466019. Elsevier B.V.","DOI":"10.1016\/j.chroma.2025.466019"},{"key":"6615_CR97","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00216-024-05242-8","volume":"416","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li L, Sutton AT, Tu Q, Zhao K, Wen E, et al. Development of a capillary zone electrophoresis method to monitor magnesium ion consumption during in vitro transcription for mRNA production. Anal Bioanal Chem. 2024;416:2941\u20139. https:\/\/doi.org\/10.1007\/s00216-024-05242-8.","journal-title":"Anal Bioanal Chem."},{"key":"6615_CR98","doi-asserted-by":"publisher","unstructured":"Lardellier P, Malburet C, Morani M, Willemin T, Rol-Moreno J, Noir A, et al. Comparative study of analytical methods for assessing mRNA integrity and identification of functional mRNA oligomers. Sci Rep. 2025;15. https:\/\/doi.org\/10.1038\/s41598-025-27563-z. Nature Research.","DOI":"10.1038\/s41598-025-27563-z"},{"key":"6615_CR99","doi-asserted-by":"publisher","first-page":"611","DOI":"10.18609\/cgti.2023.084","volume":"09","author":"T Alvine","year":"2023","unstructured":"Alvine T, Unsinn N, Long JJ, Ferraiolo J. Validation of mRNA concentration determination by slope spectroscopy technology: a matrixed approach. Cell Gene Ther Insights. 2023;09:611\u201324. https:\/\/doi.org\/10.18609\/cgti.2023.084. BioInsights Publishing, Ltd.","journal-title":"Cell Gene Ther Insights"},{"key":"6615_CR100","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1007\/s00216-025-05979-w","volume":"417","author":"Y Hoevelmann","year":"2025","unstructured":"Hoevelmann Y, Ratter A, Merkel F, Hickert S, Konishcheva E. Size-exclusion chromatography with post-column nucleic acid staining and fluorescence detection for sensitive ribonucleic acid analysis. Anal Bioanal Chem. 2025;417:4627\u201336. https:\/\/doi.org\/10.1007\/s00216-025-05979-w. Springer Science and Business Media Deutschland GmbH.","journal-title":"Anal Bioanal Chem"},{"key":"6615_CR101","doi-asserted-by":"publisher","unstructured":"Camperi J, Chatla K, Freund E, Galan C, Lippold S, Guilbaud A. Current analytical strategies for mRNA-based therapeutics. Molecules. 2025. https:\/\/doi.org\/10.3390\/molecules30071629. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/molecules30071629"},{"key":"6615_CR102","doi-asserted-by":"publisher","unstructured":"Desligni\u00e8re E, Barnes LF, Powers TW, Friese OV, Heck AJR. Characterization of intact mRNA-based therapeutics by charge detection mass spectrometry and mass photometry. Mol Ther Methods Clin Dev. 2025;33. https:\/\/doi.org\/10.1016\/j.omtm.2025.101454. Cell Press.","DOI":"10.1016\/j.omtm.2025.101454"},{"key":"6615_CR103","unstructured":"Kizekai L, Fletcher B, Fekete S, Addepalli B, Kendrick S, Chen M, et al. Optimized method conditions for mRNA characterization by SEC-MALS With GTxResolveTM premier SEC 1000 \u00c5 3 \u03bcm columns. Application note from Waters; 2025."},{"key":"6615_CR104","volume-title":"Application note biopharma authors SEC-MALS for mRNA characterization with the Agilent 1260 Infinity II multi-angle light scattering detector","author":"S Schneider","year":"2024","unstructured":"Schneider S, Rieck F. Application note biopharma authors SEC-MALS for mRNA characterization with the Agilent 1260 Infinity II multi-angle light scattering detector. Application note from Agilent Technologies; 2024."},{"key":"6615_CR105","first-page":"2023","volume-title":"Application note from Waters \u2013 Wyatt Accurate and robust mRNA-LNP encapsulation efficiency analysis by capillary gel electrophoresis with laser-induced fluorescence detection (CGE-LIF)","author":"P Wang","year":"2026","unstructured":"Wang P, Akula R. SEC-MALS method for characterizing mRNA. In: Application note from Waters \u2013 Wyatt Accurate and robust mRNA-LNP encapsulation efficiency analysis by capillary gel electrophoresis with laser-induced fluorescence detection (CGE-LIF); 2026. p. 2023."},{"key":"6615_CR106","doi-asserted-by":"publisher","unstructured":"Schultz D, M\u00fcnter RD, Cant\u00edn AM, Kempen PJ, Jahnke N, Andresen TL, et al. Enhancing RNA encapsulation quantification in lipid nanoparticles: sustainable alternatives to Triton X-100 in the RiboGreen assay. Eur J Pharm Biopharm; 2024;205. https:\/\/doi.org\/10.1016\/J.EJPB.2024.114571","DOI":"10.1016\/J.EJPB.2024.114571"},{"key":"6615_CR107","doi-asserted-by":"publisher","first-page":"e898","DOI":"10.1002\/CPZ1.898","volume":"3","author":"RE McKenzie","year":"2023","unstructured":"McKenzie RE, Minnell JJ, Ganley M, Painter GF, Draper SL. mRNA Synthesis and Encapsulation in Ionizable Lipid Nanoparticles. Curr Protoc. 2023;3:e898. https:\/\/doi.org\/10.1002\/CPZ1.898. John Wiley & Sons, Ltd.","journal-title":"Curr Protoc"},{"key":"6615_CR108","unstructured":"Accurate and robust mRNA-LNP encapsulation efficiency analysis by capillary gel electrophoresis with laser-induced fluorescence detection (CGE-LIF). 2023."},{"key":"6615_CR109","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.1021\/ACS.ANALCHEM.5C03299\/ASSET\/IMAGES\/LARGE\/AC5C03299_0007.JPEG","volume":"97","author":"A Tsalmpouris","year":"2025","unstructured":"Tsalmpouris A, Mahjoubi S, Malburet C, Daher-Hassan C, Fran\u00e7ois-Heude M, Cotte JF, et al. Anion Exchange Chromatography to Determine mRNA Encapsulation in Lipid Nanoparticles. Anal Chem. 2025;97:19275\u201382. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.5C03299\/ASSET\/IMAGES\/LARGE\/AC5C03299_0007.JPEG. American Chemical Society.","journal-title":"Anal Chem"},{"key":"6615_CR110","doi-asserted-by":"publisher","unstructured":"Malburet C, Carboni A, Guinamand S, Naik H, Fertier-Prizzon S. mRNA extraction from lipid nanoparticles. J Chromatogr A. 2024;1714. https:\/\/doi.org\/10.1016\/j.chroma.2023.464545. Elsevier B.V.","DOI":"10.1016\/j.chroma.2023.464545"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06615-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00216-026-06615-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-026-06615-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:23:26Z","timestamp":1788485006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00216-026-06615-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":110,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["6615"],"URL":"https:\/\/doi.org\/10.1007\/s00216-026-06615-x","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}